University of Montreal-ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery

    Trials, Vol. 23, Núm. 1

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  2. Paradoxical implication of BAX/BAK in the persistence of tetraploid cells

    Cell Death and Disease, Vol. 12, Núm. 11

  3. Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment: The INTERRSeCT Study

    Stroke, Vol. 52, Núm. 1, pp. 203-212

2020

  1. Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment

    Stroke, Vol. 51, Núm. 11, pp. 3232-3240

2019

  1. A randomized trial of endovascular versus surgical management of ruptured intracranial aneurysms: Interim results from ISAT2

    Neurochirurgie, Vol. 65, Núm. 6, pp. 370-376

2017

  1. Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance

    Immunological Reviews, Vol. 280, Núm. 1, pp. 165-174

2014

  1. Consensus guidelines for the detection of immunogenic cell death

    OncoImmunology, Vol. 3, Núm. 9

2009

  1. The TP53 Arg72Pro and MDM2 309GT polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

    British Journal of Cancer, Vol. 101, Núm. 8, pp. 1456-1460